Tiate, Bb Girl .
HRN: 24-06-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2023
AMPICILLIN 250MG (VIAL)
12/19/2023
12/25/2023
IV
130mg
Q12h
Potentially Septic Newborn
Waiting Final Action
Indication: Empiric Type of Infection: Unspecified Sepsis Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes